Moneycontrol
    Moneycontrol PRO
    LAMF
    LAMF

    Drugmakers

    Jump to

    • Drug samples, brand reminders to doctors should not be seen as gifts: Pharma body

    • Indian generic drugmakers may face supply shortages from China if coronavirus drags on

    • Drugmakers raise 2018 US prices, stick to self-imposed limits

    • Drugmakers in Davos shift focus to chronic diseases of poor

    • Indian drug cos have begun to adjust to FDA norms: Intas Pharma

    • Donald Trump vows to bring down drug prices, doesn't say how

    • Stop trying to defend huge price hikes: GSK CEO to drugmakers

    • India agreed to not issue compulsory drug licenses: US industry

    • Will serve Indian market as much as possible: Merck

    • Indian drugmakers see US sales hit by delay in new nods

    • EU fines Ranbaxy, others for blocking cheaper drugs

      EU antitrust regulators fined nine drugmakers a total of 146 million euros on Wednesday for blocking the supply of cheaper medicines on the market, with a penalty of 94 million euros imposed on Denmark's Lundbeck .

    • Drugmakers fall on government price control policy

      The policy, which will curtail prices of costly brands sold by domestic and international drugmakers, was approved by the government in November.

    • Ind-Swift, Wockhardt launch generic Lipitor in UK

      Drugmakers Ind-Swift and Wockhardt have jointly launched a generic version of Pfizer's cholesterol lowering drug Lipitor in the United Kingdom, the two companies said.

    • India drugs inquiry could prompt new US scrutiny

      Global drugmakers could face new US scrutiny after a report from lawmakers in India alleged abuses in that country's drug approval process, lawyers familiar with such investigations said.

    • Pharma firms want tax cuts, R&D sops boost

      Drugmakers want tax exemption deadline for export oriented unit (EOUs) to be extended and want infrastructure or priority sector status in the budget on Feb 28.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347